Endothelin antagonists and the quest for a new therapeutic option in resistant hypertension
DOI: 10.1016/s0140-6736(22)02181-xAuthor: Ralf Dechend et al.Published: 2022-12

Forum › Forums › Available Download: › DOI › Endothelin antagonists and the quest for a new therapeutic option in resistant hypertension

DOI: 10.1016/s0140-6736(22)02181-xAuthor: Ralf Dechend et al.Published: 2022-12

Tagged: 

  • This topic is empty.
Viewing 1 post (of 1 total)
  • Author
    Posts
  • April 13, 2026 at 5:48 pm #1055
    wesleyWesley
    Participant

    Title: Endothelin antagonists and the quest for a new therapeutic option in resistant hypertension
    Journal: The Lancet
    Authors: Ralf Dechend, Christian Delles
    Date: 2022-12
    DOI: 10.1016/s0140-6736(22)02181-x
    Source: Elsevier BV
    Source URL: https://doi.org/10.1016/s0140-6736(22)02181-x

  • Author
    Posts
Viewing 1 post (of 1 total)
  • You must be logged in to reply to this topic.